Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Raritan › NPI 1063497451
Lab

Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings was paid $717.47M by Medicaid between Jan 2018 and Dec 2024, across 712 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 14% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA HOLDINGS
RARITAN, NJ 08869
33aNPI1063497451assigned 12/08/2005
33bProvider typeClinical Medical Laboratory
28Total paid$717.47M
24GClaims109,455,732
24DCodes billed712
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#1 of 122
Median peer was paid$1.29M
This provider vs. median558×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$5.0M$10M$15M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201810,616,246$70.63M
201910,963,670$71.99M
202012,452,401$100.76M
202118,749,575$139.71M
202220,133,124$129.95M
202318,497,084$110.93M
2024incomplete18,043,632$93.50M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 14% 1,409,066 1,160,096 $99.27M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6.2% 2,270,062 1,330,574 $44.22M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.1% 2,732,716 2,577,686 $36.30M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 4.8% 2,718,271 2,564,191 $34.22M
80050 General health panel 4.6% 1,455,823 1,388,914 $33.10M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3.3% 2,911,722 2,762,137 $23.66M
80061 Lipid panel 2.9% 5,567,718 5,316,042 $20.85M
86480 2.6% 699,333 678,643 $18.51M
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 2.4% 839,388 662,252 $16.87M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 2.1% 49,105 47,718 $15.28M
80053 Comprehensive metabolic panel 2.1% 5,649,014 5,294,631 $14.99M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 2.0% 86,086 82,899 $14.56M
700 more codes
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.0% 1,707,214 $14.45M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.8% 1,432,602 $13.08M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.7% 494,395 $12.40M
83036 Hemoglobin; glycosylated (A1C) 1.6% 4,527,902 $11.22M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1.5% 611,389 $10.59M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.4% 680,647 $10.04M
84443 Thyroid stimulating hormone (TSH) 1.3% 3,482,722 $9.68M
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.3% 104,062 $9.50M
86769 1.3% 245,905 $9.49M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 5,745,427 $9.47M
87536 1.2% 220,843 $8.34M
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 1.1% 649,353 $7.79M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 1.0% 848,189 $7.50M
82607 <1% 1,332,083 $6.48M
86803 <1% 1,216,726 $6.09M
84439 <1% 1,913,644 $4.85M
86003 <1% 170,628 $4.36M
82746 <1% 940,704 $4.30M
83655 <1% 863,949 $3.81M
87086 Culture, bacterial; quantitative colony count, urine <1% 1,516,370 $3.76M
86235 <1% 119,472 $3.72M
87340 <1% 925,718 $3.35M
82728 <1% 931,487 $3.31M
84153 <1% 597,895 $3.30M
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 105,075 $3.25M
86360 <1% 136,841 $3.20M
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 33,907 $3.04M
84403 <1% 333,776 $2.90M
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 89,669 $2.82M
80074 <1% 245,026 $2.56M
85027 <1% 1,133,369 $2.48M
80081 <1% 51,471 $2.41M
81001 <1% 1,883,540 $2.24M
86592 <1% 1,531,485 $2.22M
83013 <1% 100,157 $2.22M
86706 <1% 537,348 $2.17M
87522 Neg quan hep c or qual rna <1% 141,772 $2.07M
83550 <1% 939,358 $1.98M
87081 <1% 786,850 $1.83M
84402 <1% 218,136 $1.81M
82043 <1% 1,027,524 $1.79M
86787 <1% 314,540 $1.79M
81329 <1% 66,309 $1.77M
82670 <1% 178,985 $1.76M
83540 <1% 1,069,989 $1.75M
87902 <1% 23,291 $1.75M
86762 <1% 339,016 $1.73M
84146 <1% 248,898 $1.70M
83001 <1% 264,914 $1.65M
86780 <1% 275,225 $1.62M
86704 <1% 367,362 $1.60M
83970 <1% 154,318 $1.57M
84480 <1% 380,689 $1.56M
86696 <1% 229,674 $1.54M
83002 <1% 239,296 $1.52M
86765 <1% 238,435 $1.41M
82570 <1% 940,071 $1.40M
86618 <1% 178,685 $1.40M
86038 <1% 379,409 $1.32M
84436 <1% 750,564 $1.31M
80048 Basic metabolic panel (calcium, ionized) <1% 706,726 $1.30M
84702 <1% 334,968 $1.29M
86708 <1% 266,676 $1.28M
87186 <1% 425,794 $1.28M
86735 <1% 221,406 $1.26M
87150 <1% 104,286 $1.20M
81003 <1% 1,859,827 $1.19M
87070 <1% 385,062 $1.18M
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 75,697 $1.14M
82784 <1% 238,288 $1.12M
86317 <1% 232,957 $1.11M
84481 <1% 215,521 $1.05M
83516 <1% 137,380 $995K
87077 <1% 357,137 $965K
86376 <1% 201,612 $950K
86617 <1% 85,733 $939K
87088 <1% 415,982 $937K
87901 <1% 5,475 $936K
86665 <1% 75,706 $935K
83735 <1% 518,792 $934K
82274 <1% 172,882 $916K
87507 <1% 11,028 $911K
84144 <1% 115,650 $908K
86140 <1% 583,991 $892K
86695 <1% 204,522 $866K
87563 <1% 69,392 $856K
36415 Collection of venous blood by venipuncture <1% 4,740,680 $834K
84479 <1% 470,161 $808K
82627 <1% 101,167 $792K
84550 <1% 590,473 $787K
83021 <1% 94,061 $779K
87480 <1% 81,656 $778K
88142 <1% 79,760 $767K
84154 <1% 120,366 $765K
87510 <1% 80,728 $758K
87660 <1% 80,537 $756K
82248 <1% 321,693 $754K
86800 <1% 149,702 $751K
80055 <1% 18,458 $731K
82652 <1% 89,066 $697K
80348 <1% 296,546 $692K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 9,224 $657K
87625 <1% 25,640 $648K
87529 <1% 60,372 $639K
86364 <1% 92,817 $597K
83020 <1% 137,169 $595K
80076 <1% 417,033 $584K
86225 <1% 138,277 $579K
86361 <1% 66,963 $577K
82785 <1% 124,750 $571K
86160 <1% 89,595 $565K
83880 <1% 65,831 $564K
85652 <1% 705,977 $559K
86008 <1% 25,553 $538K
87900 <1% 9,802 $534K
81243 <1% 40,888 $526K
88185 <1% 4,157 $516K
87209 <1% 77,937 $514K
86147 <1% 30,225 $512K
88112 <1% 25,239 $507K
82977 <1% 267,927 $503K
88141 <1% 84,819 $488K
83525 <1% 118,342 $487K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 7,157 $472K
84100 <1% 371,529 $463K
82565 <1% 358,457 $462K
86431 <1% 275,473 $462K
85610 <1% 472,655 $458K
84450 <1% 352,814 $454K
86359 <1% 41,470 $451K
87906 <1% 4,913 $436K
82947 <1% 382,447 $422K
82105 <1% 140,663 $413K
81374 <1% 21,344 $412K
87650 <1% 32,012 $407K
84445 <1% 29,596 $403K
87517 <1% 36,160 $402K
86200 <1% 114,131 $391K
84075 <1% 265,366 $377K
83615 <1% 232,624 $377K
84460 <1% 267,377 $371K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 24,426 $357K
82310 <1% 265,055 $355K
84520 <1% 332,907 $353K
82533 <1% 68,885 $352K
82465 <1% 243,470 $346K
82550 <1% 171,487 $345K
81229 <1% 4,309 $344K
82247 <1% 288,882 $344K
86258 <1% 40,373 $342K
87338 <1% 73,726 $340K
0099U <1% 2,765 $332K
88342 <1% 12,079 $329K
82040 <1% 272,016 $319K
86709 <1% 66,711 $315K
86141 <1% 71,273 $313K
86664 <1% 56,535 $303K
85730 <1% 253,712 $302K
83498 <1% 32,638 $302K
87481 <1% 22,534 $294K
86850 <1% 152,534 $288K
84295 <1% 230,094 $287K
86231 <1% 62,003 $285K
85660 <1% 148,522 $283K
84681 <1% 38,260 $279K
86255 <1% 60,335 $278K
86334 <1% 37,002 $278K
80349 <1% 110,025 $277K
86747 <1% 22,835 $275K
82024 <1% 22,948 $275K
83690 <1% 134,657 $275K
82950 <1% 194,479 $274K
87535 <1% 19,734 $268K
84305 <1% 36,940 $266K
87427 <1% 62,153 $265K
82435 <1% 228,643 $262K
80164 <1% 63,751 $258K
82378 <1% 51,204 $255K
88341 <1% 7,955 $255K
87177 <1% 78,269 $254K
84270 <1% 37,264 $252K
84155 <1% 281,704 $251K
86146 <1% 19,975 $249K
88312 <1% 16,376 $245K
84132 <1% 202,314 $244K
82672 <1% 29,521 $242K
83090 <1% 41,655 $241K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 21,667 $240K
84425 <1% 46,344 $237K
82172 <1% 47,580 $235K
87255 <1% 18,640 $233K
88262 <1% 6,772 $232K
88304 <1% 29,105 $228K
83721 <1% 94,021 $226K
83521 <1% 17,689 $225K
83520 <1% 64,905 $225K
86705 <1% 63,696 $221K
88230 <1% 7,052 $215K
81596 <1% 19,904 $213K
86677 <1% 27,476 $213K
84165 <1% 66,443 $208K
87045 <1% 62,361 $207K
81490 <1% 3,219 $206K
86355 <1% 19,809 $206K
82626 <1% 21,772 $205K
82150 <1% 106,068 $205K
86645 <1% 27,054 $204K
81401 <1% 6,538 $204K
86644 <1% 29,824 $194K
87046 <1% 62,644 $192K
84156 <1% 206,628 $191K
83921 <1% 33,494 $191K
87521 Neg quan hep c or qual rna <1% 11,965 $185K
81257 <1% 10,977 $180K
82951 <1% 47,973 $177K
88344 <1% 3,227 $175K
86777 <1% 30,611 $175K
87350 <1% 43,989 $174K
80197 <1% 48,743 $171K
86901 <1% 214,638 $170K
87075 <1% 48,357 $168K
80321 <1% 34,088 $167K
86707 <1% 38,514 $160K
86702 <1% 28,936 $155K
80299 <1% 12,700 $154K
86900 <1% 207,867 $152K
84466 <1% 42,270 $150K
84703 <1% 62,140 $146K
86666 <1% 11,358 $143K
80051 <1% 75,107 $141K
80346 <1% 64,942 $139K
85045 <1% 114,362 $137K
86694 <1% 35,048 $137K
84207 <1% 18,034 $135K
86060 <1% 45,678 $134K
86304 <1% 24,645 $133K
80358 <1% 244,835 $130K
82157 <1% 13,131 $128K
81381 <1% 4,827 $127K
87497 <1% 9,756 $127K
82088 <1% 12,529 $123K
83883 <1% 35,125 $123K
84410 <1% 6,187 $121K
86037 <1% 13,921 $121K
82397 <1% 26,683 $120K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,690 $116K
84630 <1% 35,210 $115K
82985 <1% 36,297 $114K
80365 <1% 224,136 $114K
86381 <1% 14,005 $114K
86593 <1% 47,826 $113K
80361 <1% 255,765 $113K
84432 <1% 15,963 $112K
86300 <1% 16,717 $112K
86701 <1% 27,026 $111K
81025 <1% 48,753 $110K
81479 Unlisted molecular pathology procedure <1% 2,295 $108K
80069 <1% 59,061 $108K
86753 <1% 11,270 $107K
80178 <1% 42,482 $106K
80354 <1% 271,172 $105K
87329 <1% 25,505 $104K
86671 <1% 15,193 $104K
87101 <1% 38,945 $103K
87324 <1% 27,714 $102K
84478 <1% 76,686 $101K
86663 <1% 21,192 $101K
87493 <1% 8,136 $100K
87799 <1% 11,038 $100K
86301 <1% 18,843 $97K
86738 <1% 8,493 $95K
83993 <1% 26,880 $94K
86778 <1% 19,962 $94K
80177 <1% 24,134 $91K
86341 <1% 10,820 $90K
81377 <1% 3,850 $90K
86256 <1% 16,577 $89K
86357 <1% 7,589 $89K
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision <1% 18,100 $88K
86757 <1% 6,103 $87K
83014 <1% 35,739 $86K
82787 <1% 9,767 $85K
82330 <1% 24,077 $83K
85018 <1% 121,670 $82K
83010 <1% 28,977 $82K
84238 <1% 7,687 $80K
82668 <1% 12,035 $80K
86015 <1% 15,767 $80K
82374 <1% 40,009 $80K
86356 <1% 6,678 $79K
84134 <1% 23,554 $78K
86870 <1% 10,763 $77K
82525 <1% 20,632 $77K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 2,527 $76K
82390 <1% 24,278 $76K
83718 <1% 30,996 $73K
80353 <1% 218,466 $73K
82103 <1% 18,460 $72K
80159 <1% 9,889 $71K
G0475 Hiv antigen/antibody, combination assay, screening <1% 6,801 $71K
88189 <1% 3,905 $70K
82164 <1% 18,704 $70K
86335 <1% 8,066 $69K
87631 <1% 1,433 $69K
82955 <1% 18,507 $69K
86162 <1% 13,038 $67K
82653 <1% 6,081 $66K
81500 <1% 1,126 $66K
87538 <1% 7,110 $66K
ATP17 <1% 17,146 $66K
86215 <1% 8,742 $64K
84590 <1% 23,306 $64K
84166 <1% 12,942 $63K
85014 <1% 101,581 $63K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,704 $63K
85246 <1% 12,363 $62K
84244 <1% 12,031 $61K
81361 <1% 7,159 $59K
84482 <1% 12,556 $58K
85245 <1% 11,348 $57K
87109 <1% 8,587 $56K
80202 <1% 10,251 $56K
82679 <1% 5,194 $55K
82610 <1% 14,373 $55K
85379 <1% 18,760 $54K
87184 <1% 8,656 $51K
81255 <1% 7,446 $51K
81251 <1% 7,490 $50K
85240 <1% 12,540 $50K
81206 <1% 2,236 $49K
82140 <1% 12,031 $48K
88311 <1% 14,938 $48K
87476 <1% 3,987 $48K
84446 <1% 13,409 $48K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 9,819 $46K
88184 <1% 4,154 $46K
82239 <1% 8,131 $45K
80362 <1% 80,101 $44K
81241 <1% 6,087 $44K
86308 <1% 23,716 $44K
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 10,689 $44K
81207 <1% 2,227 $43K
81383 <1% 2,067 $43K
82952 <1% 41,923 $42K
82166 <1% 4,138 $42K
84378 <1% 14,503 $42K
81200 <1% 7,595 $41K
86337 <1% 7,651 $40K
82085 <1% 15,262 $40K
84202 <1% 8,176 $40K
80156 <1% 9,624 $39K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 424 $39K
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) <1% 12,006 $39K
81412 <1% 128 $38K
82308 <1% 2,509 $38K
82232 <1% 8,299 $38K
80175 <1% 11,690 $37K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 18,142 $37K
87206 <1% 16,730 $36K
81270 <1% 2,785 $36K
ATP03 <1% 9,292 $36K
81330 <1% 7,509 $34K
85598 <1% 8,937 $34K
87076 <1% 11,143 $33K
84255 <1% 3,894 $33K
85384 <1% 10,576 $33K
87254 <1% 4,924 $32K
ATP14 <1% 14,488 $32K
83695 <1% 15,386 $32K
82553 <1% 10,160 $32K
87205 <1% 22,311 $31K
80230 <1% 1,924 $31K
81256 <1% 3,569 $31K
86340 <1% 6,216 $31K
87106 <1% 7,656 $31K
82107 <1% 1,574 $31K
83003 <1% 4,534 $30K
80145 <1% 1,822 $30K
84080 <1% 7,950 $30K
80183 <1% 8,843 $29K
87040 <1% 7,356 $29K
80324 <1% 74,942 $28K
82677 <1% 9,301 $28K
83992 <1% 136,750 $28K
84152 <1% 2,874 $28K
84442 <1% 4,153 $28K
85613 <1% 17,136 $28K
83835 <1% 8,169 $27K
87634 <1% 914 $26K
80165 <1% 8,296 $26K
81291 <1% 3,189 $26K
82747 <1% 4,503 $26K
81260 <1% 7,493 $26K
81290 <1% 7,485 $25K
81242 <1% 7,491 $24K
83519 <1% 5,086 $24K
80185 <1% 6,410 $24K
87999 <1% 2,127 $23K
ATP08 <1% 11,187 $23K
ATP11 <1% 3,914 $23K
82104 <1% 5,677 $22K
87328 <1% 5,916 $22K
85060 <1% 4,100 $22K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 10,259 $22K
84591 <1% 7,013 $22K
82642 <1% 3,003 $22K
81219 <1% 444 $22K
82552 <1% 5,299 $22K
84484 <1% 6,268 $22K
85306 <1% 5,185 $21K
81517 <1% 593 $21K
85597 <1% 5,051 $21K
81209 <1% 7,523 $21K
81240 <1% 4,083 $21K
81402 <1% 246 $20K
85004 <1% 15,234 $20K
84143 <1% 1,762 $20K
81244 <1% 3,741 $20K
80320 <1% 6,036 $19K
ATP15 <1% 4,898 $19K
82180 <1% 7,808 $19K
89055 <1% 13,266 $19K
86336 <1% 10,630 $19K
85048 <1% 35,353 $18K
81338 <1% 180 $18K
80323 <1% 13,823 $18K
84597 <1% 5,240 $18K
86005 <1% 10,876 $18K
86036 <1% 3,593 $18K
82340 <1% 9,605 $18K
80347 <1% 146,505 $18K
86658 <1% 1,431 $18K
86631 <1% 4,920 $18K
87486 <1% 22,337 $17K
83631 <1% 2,837 $17K
87581 <1% 22,492 $17K
80356 <1% 27,149 $17K
83825 <1% 4,124 $17K
86880 <1% 7,651 $17K
83704 <1% 4,270 $17K
83789 <1% 2,616 $16K
82542 <1% 3,451 $16K
88307 <1% 277 $16K
85041 <1% 34,750 $16K
85007 <1% 19,409 $16K
87468 <1% 787 $15K
80184 <1% 4,152 $15K
83625 <1% 3,543 $15K
80371 <1% 119,768 $15K
80414 <1% 601 $15K
88237 <1% 234 $15K
83527 <1% 2,826 $15K
80375 <1% 4,731 $15K
ATP13 <1% 1,899 $14K
ATP18 <1% 4,055 $14K
80158 <1% 2,866 $13K
82681 <1% 1,105 $13K
0014M <1% 244 $13K
84252 <1% 3,148 $13K
82705 <1% 7,328 $13K
85303 <1% 4,190 $13K
85670 <1% 12,011 $13K
84140 <1% 1,956 $13K
87807 <1% 3,317 $12K
87469 <1% 481 $12K
0003M <1% 163 $12K
80359 <1% 174,462 $12K
87116 <1% 3,375 $12K
82575 <1% 7,731 $12K
86148 <1% 1,698 $11K
80235 <1% 2,521 $11K
ATP10 <1% 3,016 $11K
87015 <1% 3,642 $11K
83930 <1% 4,893 $11K
83935 <1% 6,692 $10K
80337 <1% 123,294 $10K
80195 <1% 2,850 $10K
87420 <1% 3,032 $10K
81279 <1% 97 $10K
82384 <1% 2,965 $10K
ATP09 <1% 2,302 $10K
87593 <1% 703 $10K
80162 <1% 3,773 $10K
85300 <1% 4,106 $10K
87903 <1% 26 $10K
80201 <1% 4,249 $9K
82175 <1% 2,953 $9K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 136 $9K
82657 <1% 1,323 $9K
87425 <1% 1,855 $9K
ATP04 <1% 1,829 $9K
80203 <1% 1,869 $9K
ATP07 <1% 2,601 $9K
89060 <1% 3,262 $9K
86682 <1% 1,867 $9K
86804 <1% 1,424 $9K
0024U <1% 1,507 $8K
84300 <1% 7,195 $8K
85049 <1% 5,941 $8K
80364 <1% 118,938 $8K
87496 <1% 751 $8K
82530 <1% 2,674 $8K
88271 <1% 309 $8K
81405 <1% 101 $8K
81364 <1% 273 $7K
87102 <1% 2,616 $7K
87467 <1% 450 $7K
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 2,203 $7K
87484 <1% 341 $7K
82523 <1% 1,848 $7K
99001 <1% 13,217 $7K
80326 <1% 118,287 $6K
82731 <1% 195 $6K
80373 <1% 203,591 $6K
83088 <1% 690 $6K
88275 <1% 191 $6K
87207 <1% 1,854 $6K
80372 <1% 197,903 $6K
84433 <1% 468 $5K
83874 <1% 1,233 $5K
85302 <1% 2,309 $5K
89051 <1% 3,254 $5K
85732 <1% 12,667 $5K
86606 <1% 1,407 $5K
85305 <1% 2,559 $5K
80367 <1% 131,984 $5K
86161 <1% 965 $5K
86790 <1% 1,014 $5K
80370 <1% 132,186 $5K
80368 <1% 133,645 $5K
86615 <1% 729 $5K
86316 <1% 1,328 $5K
86305 <1% 372 $5K
87210 <1% 2,102 $4K
82595 <1% 2,983 $4K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 18,701 $4K
82379 <1% 1,940 $4K
80338 <1% 122,457 $4K
80360 <1% 122,223 $4K
80344 <1% 121,674 $4K
80366 <1% 143,040 $4K
84133 <1% 3,198 $4K
81332 <1% 224 $4K
82656 <1% 1,274 $4K
99199 Unlisted special service, procedure or report <1% 10,609 $4K
S3600 Stat laboratory request (situations other than s3601) <1% 5,232 $4K
ATP02 <1% 1,580 $4K
80334 <1% 122,217 $3K
87230 <1% 443 $3K
81599 <1% 1,792 $3K
82941 <1% 747 $3K
80377 <1% 121,003 $3K
86332 <1% 290 $3K
0097U <1% 1,442 $3K
85705 <1% 4,026 $3K
80357 <1% 123,221 $3K
83605 <1% 1,260 $3K
80345 <1% 5,374 $3K
0001M <1% 61 $3K
81015 <1% 3,712 $3K
ATP16 <1% 636 $3K
80355 <1% 142,821 $3K
87252 <1% 506 $3K
80331 <1% 117,588 $3K
80369 <1% 853 $3K
81443 <1% 1,468 $2K
82436 <1% 2,045 $2K
86611 <1% 1,465 $2K
85247 <1% 704 $2K
85385 <1% 1,478 $2K
85301 <1% 1,461 $2K
80220 <1% 511 $2K
80341 <1% 121,808 $2K
84260 <1% 254 $2K
87511 <1% 87 $2K
86041 <1% 271 $2K
84560 <1% 1,230 $2K
88289 <1% 953 $2K
87905 <1% 993 $2K
89321 <1% 933 $2K
80325 <1% 359 $2K
83986 <1% 1,742 $2K
86226 <1% 345 $2K
85307 <1% 307 $2K
87168 <1% 768 $2K
80352 <1% 105 $2K
86703 <1% 153 $2K
80169 <1% 326 $1K
80374 <1% 3,293 $1K
84145 <1% 135 $1K
87172 <1% 633 $1K
ATP12 <1% 339 $1K
82010 <1% 496 $1K
88164 <1% 346 $1K
80333 <1% 17 $1K
84999 <1% 120 $1K
86022 <1% 237 $1K
86051 <1% 89 $1K
82963 <1% 60 $1K
ATP05 <1% 204 $1K
82300 <1% 395 $1K
81422 <1% 5,797 $895.68
80503 <1% 100 $856.15
81408 <1% 40 $773.36
85549 <1% 83 $735.61
80332 <1% 10,202 $728.75
82373 <1% 88 $728.09
82540 <1% 986 $724.18
86710 <1% 223 $714.54
86692 <1% 338 $710.12
84206 <1% 89 $707.69
83937 <1% 49 $672.37
86794 <1% 55 $648.81
80150 <1% 88 $647.42
86906 <1% 146 $639.19
80171 <1% 134 $606.60
80376 <1% 351 $575.33
86309 <1% 133 $567.76
85250 <1% 206 $529.98
ATP06 <1% 180 $509.57
84588 <1% 44 $506.64
85270 <1% 148 $500.01
82375 <1% 66 $467.35
85415 <1% 47 $443.49
84540 <1% 250 $441.14
G0124 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician <1% 460 $422.71
84105 <1% 310 $393.01
83698 <1% 42 $386.71
87912 <1% 12 $359.13
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 21 $331.24
ATP19 <1% 97 $324.06
87899 <1% 55 $322.13
87110 <1% 43 $308.38
86366 <1% 31 $281.90
84181 <1% 53 $272.51
ATP20 <1% 47 $262.90
82380 <1% 88 $256.75
80179 <1% 42 $237.16
36416 <1% 2,365 $236.39
82160 <1% 26 $228.37
80180 <1% 54 $217.64
83529 <1% 28 $210.95
86043 <1% 150 $188.69
80339 <1% 490 $186.70
86042 <1% 140 $183.06
80157 <1% 39 $180.78
88187 <1% 14 $170.83
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 19 $163.29
82108 <1% 12 $139.13
86602 <1% 52 $133.42
84585 <1% 182 $130.60
86849 <1% 244 $114.94
87449 <1% 156 $109.65
85230 <1% 13 $108.85
80186 <1% 30 $108.71
80200 <1% 14 $104.09
87149 <1% 20 $97.62
86609 <1% 247 $93.75
83945 <1% 195 $81.26
85220 <1% 13 $80.40
83497 <1% 55 $79.38
83915 <1% 12 $75.25
82270 <1% 58 $67.61
86001 <1% 89 $60.13
87140 <1% 31 $54.99
86331 <1% 40 $53.78
86632 <1% 1,818 $50.04
80198 <1% 14 $42.74
87299 <1% 1,179 $40.11
87279 <1% 1,178 $33.47
87276 <1% 1,188 $33.01
87280 <1% 1,186 $30.65
87260 <1% 1,178 $30.05
82365 <1% 742 $29.92
87275 <1% 1,188 $29.75
86628 <1% 43 $27.21
85420 <1% 12 $25.23
82360 <1% 342 $16.52
89160 <1% 13 $15.96
84163 <1% 1,983 $13.74
82139 <1% 2,099 $13.50
83919 <1% 818 $13.16
82945 <1% 13 $12.43
81162 0% 116 $0.00
82017 0% 1,196 $0.00
84311 0% 58 $0.00
81373 0% 48 $0.00
86352 0% 223 $0.00
80327 0% 94 $0.00
81400 0% 14 $0.00
99213 Doctor's office visit, returning patient (routine) 0% 348 $0.00
ATP23 0% 14 $0.00
82507 0% 219 $0.00
99080 0% 40,754 $0.00
83876 0% 88 $0.00
88120 0% 343 $0.00
83918 0% 68 $0.00
82131 0% 58 $0.00
84392 0% 27 $0.00
83951 0% 27 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaSan Diego, CA$147.14M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.